Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-10-001517
Filing Date
2010-04-16
Accepted
2010-04-15 20:02:24
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2009_centracan.htm 10-K 451556
2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 f10k2009ex31i_centracan.htm EX-31.1 10857
3 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 f10k2009ex31ii_centracan.htm EX-31.2 10789
4 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 f10k2009ex32i_centracan.htm EX-32.1 7030
5 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 f10k2009ex32ii_centracan.htm EX-32.2 6986
  Complete submission text file 0001213900-10-001517.txt   488596
Mailing Address 65 EAST 55TH STREET NEW YORK NY 10022
Business Address 65 EAST 55TH STREET NEW YORK NY 10022 (212) 451-2254
CENTRACAN INC (Filer) CIK: 0001073101 (see all company filings)

EIN.: 650736042 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52910 | Film No.: 10753287
SIC: 8071 Services-Medical Laboratories